Axa’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-774,200
| Closed | -$686K | – | 1211 |
|
|
2022
Q4 | $686K | Buy |
774,200
+346,900
| +81% | +$307K | ﹤0.01% | 943 |
|
|
2022
Q3 | $671K | Hold |
427,300
| – | – | ﹤0.01% | 921 |
|
|
2022
Q2 | $859K | Buy |
+427,300
| New | +$859K | ﹤0.01% | 900 |
|
|
2022
Q1 | – | Sell |
-29,800
| Closed | -$139K | – | 1262 |
|
|
2021
Q4 | $139K | Hold |
29,800
| – | – | ﹤0.01% | 1131 |
|
|
2021
Q3 | $227K | Buy |
+29,800
| New | +$227K | ﹤0.01% | 1174 |
|
|
2020
Q2 | – | Sell |
-68,600
| Closed | -$126K | – | 1308 |
|
|
2020
Q1 | $126K | Hold |
68,600
| – | – | ﹤0.01% | 1133 |
|
|
2019
Q4 | $232K | Sell |
68,600
-2,400
| -3% | -$8.12K | ﹤0.01% | 1113 |
|
|
2019
Q3 | $152K | Hold |
71,000
| – | – | ﹤0.01% | 1262 |
|
|
2019
Q2 | $190K | Sell |
71,000
-58,300
| -45% | -$156K | ﹤0.01% | 1236 |
|
|
2019
Q1 | $614K | Sell |
129,300
-160,800
| -55% | -$764K | ﹤0.01% | 1072 |
|
|
2018
Q4 | $696K | Hold |
290,100
| – | – | ﹤0.01% | 1029 |
|
|
2018
Q3 | $1.28M | Buy |
290,100
+219,500
| +311% | +$965K | ﹤0.01% | 981 |
|
|
2018
Q2 | $508K | Buy |
+70,600
| New | +$508K | ﹤0.01% | 1132 |
|